Daily Highlights

DIA 2015 51st Annual Meeting


Daily Highlights: Monday, June 15

Open Plenary
 

Plenary Session & Keynote Address
Keynote Speaker: Daniel Burrus

Top level senior leadership from four of the most influential global regulators discussed current multilateral and bilateral initiatives aimed to facilitate better interaction and coordination.

Read the Tuesday issue of our onsite Show Daily



How Pharmaceutical Companies and CROs Are Harnessing Big Data and Cloud Computing to Increase R&D Innovation, Efficiency, and Collaboration

DIA 2015 

This session explored new enabling technology and approaches that can help trial sponsors and clinical research organizations (CRO) fundamentally change, adapt and collaborate more effectively.

View Video

   

International Regulatory Convergence: Collaboration, Cooperation and Global Governance

DIA 2015

Top level senior leadership from four of the most influential global regulators discussed current multilateral and bilateral initiatives aimed to facilitate better interaction and coordination.

View Video

   

Medical Heroes Appreciation Walk

DIA 2015

We had an excellent turnout – several hundred registrants participated in the Medical Heroes Appreciation Walk this year.



Daily Highlights: Tuesday, June 16

DIA 2015
 
 

Tuesday Plenary: Disruptive Forces in Health Care Innovation: Where Are They Leading Us?

Panelists discussed the impact of disruptive technology as it relates to health care innovation, and the challenges that organizations, individuals, and regulators are facing with disruptive technology.

View Video



Breakthrough Medicines or Affordable
Health Care: Do We Have to Choose?

DIA 2015

In this forum, speakers explored the potentially competing demands for innovative breakthrough medicines, regulatory initiatives, and new business practices geared toward boosting innovation while lowering treatment costs.

View Video

 

 

DIA 2015


Read the Wednesday issue
of our onsite Show Daily

   

Student Poster Session Awards

DIA 2015

1st Place: Role of Purinergic P2X4Rs in Regulating Dopamine Dependent Signaling Cascades within Basal Ganglia Circuitry, Presented by Sheraz Khoja, MSc: University of Southern California

2nd Place: The Signaling Effects of Stacked FDA Designations, Presented by Kathleen Miller, MS, PhD: University of North Carolina at Chapel Hill

3rd Place: Spontaneous Adverse Drug Reactions Reporting by Patients in Canada: A Multi-Method Study, Presented by Rania Dweik: University of Ottawa, Canada

Read More in Wednesday's Show Daily



Daily Highlights: Wednesday, June 17

DIA 2015
 
 

21st Century Cures: Which Are the Most Transformative Provisions and How Do They Accomplish Major Change?

In this forum, members of Congress, FDA, and other key stakeholders discussed how to better understand where this initiative is in the process, and what our panelists believe the most transformative provisions will be.

View Video



Read the Thursday issue of our onsite Show Daily



The Future of Clinical Trial Data Sharing

DIA 2015 

This distinguished panel examined the potential barriers to the sharing of clinical trial data, and how these barriers may affect the future of clinical trial data sharing.

View Video

   

No More Crying Wolf: FDA Issues Final Rule on Changes to Pregnancy and Lactation Information in Drug Labeling

DIA 2015

FDA, industry, and academia covered the final Pregnancy and Lactation Labeling Rule which sets the new content and formatting requirements for pregnancy and breastfeeding information in labeling.

View Video

   

TransCelerate Collaboration: Harmonization Efforts to Find Solutions to Critical Industry Challenges

DIA 2015

Panelists examined how 21 participating member companies are driving innovation to address clinical trial execution pain points through their 12 chartered work streams.

View Video

             
             

Precision Medicine: Where Is the Technology Taking Us, How Fast
and Who Is Driving?

DIA 2015 

The panel explored where technology and science is taking us, and debated the best way to integrate results of genomics into clinical care in this new era of genetics.

View Video

   

Power Up! Session:
Give Your Brain a Break

DIA 2015

Attendees listened as ten individuals shared five-minute presentations of their distinctive experiences and stories in another inspirational session.

View Video

   

Voted Best Professional Posters from this Year's Program

First Place: Ex-US Sites in A Multinational Study: Should They Be Included Under a US IND or Not?, Jacqueline M. Kline, PhD, Senior Director Global Regulatory Affairs, Eisai Inc.

Second Place: Clinical Monitoring Liaison, a New Oversight Role as a Practical Approach to Sponsor Involvement in Outsourced Trials, Annelies Legters, MS, Director Clinical Operations Europe, FORUM Pharmaceuticals International BV, Netherlands

Third Place: Exploration of Protocol Complexity Factors and Impact on Protocol Variance Rates in a Subset of Clinical Trials, Paige Ellison Manager, Clinical Trial Management, Seattle Genetics, Inc.



Daily Highlights: Thursday, June 18

Featured Videos:        

 

       

An Insider’s View of Cooperation
Between the EMA and CDER/FDA:
Question Time

DIA 2015  

For the first time, members from EMA and CDER/FDA Leadership discussed bilateral cooperation aimed at bringing new medicines to patients throughout the world while assuring consistent standards of quality.

View Video

 

CDER Town Hall

DIA 2015

Leaders from the US FDA’s CDER Division participated in this interactive offering where members of the audience were able to submit questions.

View Video

  Read Highlights
in the Onsite Show Daily

DIA 2015

Sunday | Monday
Tuesday | Wednesday

 

#DIA2015 in the News

21st Century Cures: What it could mean for CROs (Dispatches from DIA 2015)

DIA starts with a flurry of hires, deals and product updates

PatientsLikeMe-FDA research collaboration seeks to increase patient experience of drugs in post market reviews

Survey: Electronic Processes Increasingly Replacing Paper In Clinical Trials

US FDA teams with PatientsLikeMe to access post-market patient data

FDA links with PatientsLikeMe

FDA Taps Online Patient Database To Gain Access To Patient-Reported MS Health Data


Top Tweets

DIA 2015


Onsite Image Gallery

Opening Plenary